Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Gastroenterol Hepatol (N Y). 2012 Aug;8(8):504-12.

Vaccination issues in patients with inflammatory bowel disease receiving immunosuppression.

Author information

  • 1Dr. Dezfoli is a PGY-3 Resident in Internal Medicine at Cedars-Sinai Medical Center in Los Angeles, California. Dr. Melmed is the Director of Clinical Trials at the Inflammatory Bowel Disease Center at Cedars-Sinai Medical Center and an Assistant Clinical Professor of Medicine at the David Geffen School of Medicine at the University of California, Los Angeles, both in Los Angeles, California.

Abstract

Treatment regimens for Crohn's disease and ulcerative colitis increase susceptibility to infections, many of which can be prevented by vaccinations. Increased awareness concerning vaccine-preventable diseases has led to several studies investigating the immunologic responses to vaccines in immunosuppressed patients with inflammatory bowel disease. This review provides an overview of the evidence-based rationale for currently accepted recommendations regarding the use of both inactivated and live vaccines in this unique population.

KEYWORDS:

Inflammatory bowel disease; immunization; infection; pertussis; pneumococcal vaccine; vaccination

PMID:
23293563
[PubMed]
PMCID:
PMC3533208
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk